| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Biological and predictive role of ERCC1 polymorphisms in cancer
|
Formica, V.
|
|
2017
|
111 |
C |
p. 133-143
11 p.
|
artikel
|
| 2 |
Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients
|
Mehta, M.
|
|
2017
|
111 |
C |
p. 60-65
6 p.
|
artikel
|
| 3 |
Editorial Board
|
|
|
2017
|
111 |
C |
p. IFC-
1 p.
|
artikel
|
| 4 |
Effectiveness of antiangiogenic drugs in glioblastoma patients: A systematic review and meta-analysis of randomized clinical trials
|
Lombardi, Giuseppe
|
|
2017
|
111 |
C |
p. 94-102
9 p.
|
artikel
|
| 5 |
Epigenetic control of gene expression: Potential implications for cancer treatment
|
Perri, F.
|
|
2017
|
111 |
C |
p. 166-172
7 p.
|
artikel
|
| 6 |
Immunotherapy for the treatment of multiple myeloma
|
Jung, Sung-Hoon
|
|
2017
|
111 |
C |
p. 87-93
7 p.
|
artikel
|
| 7 |
Long non-coding RNA CASC2 in human cancer
|
Palmieri, Giuseppe
|
|
2017
|
111 |
C |
p. 31-38
8 p.
|
artikel
|
| 8 |
Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early Breast cancer: A systematic review and meta-analysis
|
Roberts, Kate
|
|
2017
|
111 |
C |
p. 66-80
15 p.
|
artikel
|
| 9 |
Multimodal treatment of resectable pancreatic ductal adenocarcinoma
|
Silvestris, Nicola
|
|
2017
|
111 |
C |
p. 152-165
14 p.
|
artikel
|
| 10 |
Pembrolizumab’s non-cross resistance mechanism of action successfully overthrown ipilimumab
|
Wahid, Mohd
|
|
2017
|
111 |
C |
p. 1-6
6 p.
|
artikel
|
| 11 |
Proton Pump Inhibitors in cancer patients: How useful they are? A review of the most common indications for their use
|
Numico, Gianmauro
|
|
2017
|
111 |
C |
p. 144-151
8 p.
|
artikel
|
| 12 |
Regulatory roles of brain-specific angiogenesis inhibitor 1(BAI1) protein in inflammation, tumorigenesis and phagocytosis: A brief review
|
Mathema, Vivek Bhakta
|
|
2017
|
111 |
C |
p. 81-86
6 p.
|
artikel
|
| 13 |
Risk assessment in paediatric glioma—Time to move on from the binary classification
|
Dodgshun, A.J.
|
|
2017
|
111 |
C |
p. 52-59
8 p.
|
artikel
|
| 14 |
Serum and tissue markers in colorectal cancer: State of art
|
Berretta, Massimiliano
|
|
2017
|
111 |
C |
p. 103-116
14 p.
|
artikel
|
| 15 |
Targeting HIF-2 α in clear cell renal cell carcinoma: A promising therapeutic strategy
|
Martínez-Sáez, Olga
|
|
2017
|
111 |
C |
p. 117-123
7 p.
|
artikel
|
| 16 |
The cornerstone K-RAS mutation in pancreatic adenocarcinoma: From cell signaling network, target genes, biological processes to therapeutic targeting
|
Jonckheere, Nicolas
|
|
2017
|
111 |
C |
p. 7-19
13 p.
|
artikel
|
| 17 |
The synergistic effect of radiotherapy and immunotherapy: A promising but not simple partnership
|
Chajon, Enrique
|
|
2017
|
111 |
C |
p. 124-132
9 p.
|
artikel
|
| 18 |
Understanding c-MET signalling in squamous cell carcinoma of the head & neck
|
Szturz, P.
|
|
2017
|
111 |
C |
p. 39-51
13 p.
|
artikel
|
| 19 |
What is the role of postoperative re-irradiation in recurrent and second primary squamous cell cancer of head and neck? A literature review according to PICO criteria
|
Merlotti, Anna
|
|
2017
|
111 |
C |
p. 20-30
11 p.
|
artikel
|
Tijdschrift beschrijving